For the posters presentations you will be provided with enough space to show your scientific poster 90 cm width x 120 cm hight (2.9 feet width by 3.9 feet high).
Mounting posters: To mount your poster you can do it the day before or from 8:00 am to 10:00 am to make sure your poster will be visible all day by most of the participants. The display of the posters will be in BERLIN Hall 1 and 2, 2nd floor.
Remember that posters sessions will be at the end of each day. Please be in front of your poster at least 30 minutes to present it and then feel free to visit the other posters.
There are two posters sessions at 6:00 – 7:30 pm
Thursday 21st: Session 1. Epidemiology/Phylogenetics, Modeling/Public Health/Burden, Vector Biology, Vector Control, Virology
| Thursday April 21st | see the pdf file | ||
| Poster session: Epidemiology/Phylogenetics, Modeling/Public Health/Burden, Vector Biology, Vector Control, Virology | |||
| Highlighted posters | |||
| Poster # | Name of presenter | Title | Session |
| H-1 | Erwin Camacho | Space-Time cluster analysis of dengue fever ocurrence and vector detection by MosquiTRAP in Sincelejo-Colombia | Vector Control |
| H-2 | Fernando Quintella | COST ESTIMATION OF DENGUE PREVENTION AND VECTOR CONTROL IN BRAZIL | Vector Control |
| H-3 | Emily Gallichotte | Co-infection with dengue serotypes to produce chimeric virions | Virology |
| H-4 | Lorenzo Caceres-Carrera | Short-term suppression of Aedes aegypti using genetic control | Vector Control |
| H-5 | Maisa Carla Pereira Parra | A New Entomological Indicator for Dengue Occurence Based on Adult Mosquitoes Trapping and GIS Tools | Epidemiology/Modeling |
| H-6 | Marco Horta | Spatiotemporal Patterns of Chikungunya Transmission in Feira de Santana City, Brazil | Epidemiology |
| H-7 | Margot Enguehard | Dengue and Chikungunya virus: interactions during coinfection in mosquito cells | Virology |
| H-8 | Nicole Zitzmann | Iminosugars inhibit dengue virus production via inhibition of endoplasmic reticulum alpha-glucosidases – not glycolipid processing enzymes | Antivirals |
| H-9 | Diana Sarmiento | DENGUE AND DIARRHEA CONTROL IN RURAL PRIMARY SCHOOLS IN COLOMBIA | Epidemiology |
| H-10 | Patricia Sequeira | Overview of Fatal Cases Due to Dengue in Brazil | Epidemiology |
| H-11 | Rajendra Raut | Development of Immuno-assay to distinguish between Mature and Immature Dengue Virus | Virology |
| H-12 | Sebastian Aguirre | cGAS is degraded in Dengue virus infected cells | Virology |
| H-13 | Shuzhen Sim | Identifying gut microbiota-driven mechanisms behind vector competence for dengue | Vector Biology |
| H-14 | Stalin Vilcarromero | Direct Hospitalization Costs Caused By Non-Dengue Arboviral Infections in Public Hospitals and Primary Care Facilities of the Peruvian Amazon Between 2011 and 2014 | Epidemiology/Socio-economic Burden |
| H-15 | Tauyne Menelgado Pinheiro | Biological Characterization of Two Dengue 1 Co-Circulating Lineages in Brazil Revels Markers of Epidemiological Fitness | Phylogenetics/Epidemiology |
| H-16 | Vanessa Sarathy | Comparison between two genotype II DENV-3 strains in AG129 mice | Virology |
| H-17 | William Aviles | Improving Epidemiological and Laboratorial Surveillance of Dengue in Nicaragua | Epidemiology |
| H-18 | Yesseinia Anglero-Rodriguez | Mosquito mycobiota potentially increases dengue transmission | Vector Biology |
| H-41 | Rubing Chen | Vector Biology | |
| Regular posters | |||
| R-1 | Adriano Mondini | Detection of dengue virus in egg-hatched mosquitoes collected in a city from Brasil | Vector Biology |
| R-2 | Adriano Mondini | Spatial Analysis of Six Years of Dengue Transmission in a City from Brasil | Epidemiology- Modeling |
| R-3 | Adriano Mondini | The Use of Spatial Analysis for Dengue: Challenges and Pitfalls | Epidemiology- Modeling |
| R-4 | Shehana Tahir | A Preliminary Report of the Ongoing Epidemics of Zika in the Department of Risaralda, Colombia | Epidemiology |
| R-5 | Alma Ortiz | Bacterial diversity of females mosquitoes Aedes Aegypti and Aedes Albopictus in Panama | Vector Biology |
| R-6 | Anayansi Valderrama | Not detect of a point mutation in the voltage-gated sodium cannel of Aedes albopictus (Skuse) (Diptera: Culicidae) from Panama. | Vector Biology |
| R-7 | Andrea Gómez-Bravo | Monitoring of insecticide resistance in Aedes aegypti populations in Argentina | Vector Control |
| R-8 | Andrew McKemey | Genetically engineered mosquito for control of dengue vector – Aedes aegypti | Vector Control |
| R-9 | Anselmo McDonald | Aedes aegypti infestation surveillance using climatic data in Panama | Vector Biology-control |
| R-10 | Arturo Rebollon | Remote Sensing and Community Involvement: Best Way to Control Dengue | Epidemiology |
| R-11 | Betania Drumond | Phylodynamics of Dengue Virus in Minas Gerais, Southeast Brasil | Epidemiology-Phylogenetics |
| R-12 | Bradley J. Blitvich | Discovery of Novel Flaviviruses, Bunyaviruses and Rhabdoviruses Inmexican Mosquitoes | Epidemiology-Phylogenetics |
| R-13 | Carlos Alberto Marques de Carvalho | DENGUE VIRUS SUPPRESSES THE CYTOPATHIC EFFECT OF YELLOW FEVER VIRUS | Virology |
| R-14 | Carlos Machain Williams | Genetic characterization of chikungunya virus isolates from humans and mosquitoes in Yucatan, México | Virology |
| R-15 | Claudia Duarte dos Santos | Zika Virus in Brasil : Characterization of Circulating Virus and Development of Diagnostic Reagent | Epidemiology-Phylogenetics |
| R-16 | Claudio Soto Garita | Molecular Characterization of Two Significant Dengue Outbreaks in Costa Rica | Epidemiology-Phylogenetics |
| R-17 | Crystyan Siles | An Outbreak of Guaroa Virus in the Northern Peruvian Amazon Around Iquitos | Epidemiology |
| R-18 | Daniel Cardoso Camara | Relationship Between Dengue and Socioeconomic Conditions in Itaborai, Brasil | Epidemiology |
| R-19 | Danielle Malta Lima | Dengue Fever’s Transmission on Asymptomatic and Oligosymptomatic Individuals –Soroepidemiological Study | Epidemiology |
| R-20 | Danila Vedovello | Molecular Surveillance of Dengue Virus During Nine Epidemic Seasons | Epidemiology-Phylogenetics |
| R-21 | Debora C. Kajeguka | Prevalence of Dengue and Chikungunya Viruses in North-Eastern Tanzania | Epidemiology |
| R-22 | Diana Patricia Londono Buritica | Coinfection Dengue – Leptospirosis in Quindio, 2007-2013 | Epidemiology |
| R-23 | Domingo Montada | Strategies in Santiago de Cuba with Deltamethrin for controlling Aedes aegypt) | Vector Control |
| R-24 | Enrique Mamani | Circulation of Two Lineages of Dengue 3, Genotype Iii in Peru | Epidemiology-Phylogenetics |
| R-25 | Erik Jair Jhonston Vela | Epidemiology of Dengue. Loreto 2015 | Epidemiology |
| R-26 | Erwin Camacho | Dengue, Chikungunya and Zika Viruses Circulation in Sucre – Colombia | Epidemiology |
| R-27 | Eugenia Corrales-Aguilar | Susceptibility of Neotropical Primary Bat Cell Lines to Dengue Infection | Virology |
| R-28 | F. B SANTOS | EXPERIMENTAL INFECTION OF AEDES AEGYPTI BY TWO DISTINCT VARIANTS OF DENV-3 | Vector Biology |
| R-29 | Fernanda M. C. de Araujo | First Documented Cases of Zika Virus Infection in Ceará, Brasil | Epidemiology |
| R-30 | Gabriela Cardoso Caldas | MURINE MODEL FOR DENGUE VIRUS 3: MORPHOLOGICAL AND MOLECULAR STUDIES | Virology |
| R-31 | Gerusa Gibson | Frequency and distribution of Aedes aegypti (Diptera: Culicidae) in non-residential premises of an endemic municipality of Brasil | Vector ecology |
| R-32 | Hussein Sánchez-Arroyo | BIOLOGICAL EFFECTIVENESS OF RESIDUAL SPRAYING WITH ACTELLIC® 300CS (PIRIMIPHOS-METHYL 300g/L) ON Aedes aegypti. | Vector Control |
| R-33 | Hussein Sánchez-Arroyo. | EVALUATION OF ACUGARD® TABLET AND GRANULAR FORMULATIONS AGAINST Aedes aegypti | Vector Control |
| R-34 | Inaki Deza-Cruz | Seroconversion to Dengue and Chikungunya in Adults in St. Kitts. | Epidemiology |
| R-35 | Isabel Álvarez-de Mora | Repellent Effect of Hyptis suaveolens against Aedes on human skin | Vector Control |
| R-36 | Isabel Cruz-Zazueta | Changes on Sialic Acid in macrophages infected by Dengue Virus | Virology |
| R-37 | Yamilka Diaz | Unusual Pattern of Chikungunya Epidemic in the Americas: Panama Experience | Epidemiology |
| R-38 | Yamilka Diaz | Dengue in Panama: 20 Years of History. | Epidemiology |
| R-39 | Jhon Carlos Castano | Deaths from Dengue in Quindio – Colombia 2007-2014 | Epidemiology |
| R-40 | Jose Joaquin Carvajal Cortes | Social Determinants of Spatial Distribution of Dengue at Brasil ian Borders | Epidemiology- Modeling |
| R-41 | José Manuel Reyes Ruiz | Dengue virus particles production in mosquito cells persistently infected | Virology |
| R-42 | Juan Alejandro Sabogal | Acute Chikungunya in the Department of Risaralda, Colombia: An Analysis of 38 Weeks of Epidemics with 3,445 Cases | Epidemiology |
| R-43 | Juan David Rivera Duran | NS5 protein modeling of dengue 2 and docking with Curcumin | Virology |
| R-44 | Julia S. Ampuero | Correlation between severity of clinical Dengue disease and viral load | Virology |
| R-45 | Leticia Castillo | Chikungunya Behavior in the Dengue Epidemic in Guatemala | Epidemiology |
| R-46 | Lina Casadiegos-Patiño | Stegomyia aegypti breeding-sites and immature indices in two Mexican towns. | Vector ecology |
| R-47 | Luisa Arbelaez | Epidemiological Aspects of Dengue Infection in a in Children and Adults of Paris, City of Bello, Colombia | Epidemiology |
| R-48 | Mabel Carabali | Dengue Vaccine Initiative Project: Burden of Dengue Fever in Children and Adults of Piedecuesta- Santander, Colombia | Epidemiology- Socio-economic burden |
| R-49 | Maira Aguiar | The impact of the newly licensed dengue vaccine in endemic countries | Epidemiology- Modeling |
| R-50 | Maira Aguiar | The Impact of Empirical Data Analysis on Public Health Practical Intervention | Epidemiology- Modeling |
| R-51 | Maisa Carla Parra Pereira | Evaluation of a Possible Sentinel Surveillance Systems for Dengue Transmission | Epidemiology- Modeling |
| R-52 | Mânlio Mota Tasso | Complete Genome of Mayaro Virus Imported from Amazonian Basin, Brasil | Epidemiology, Phylogenetics |
| R-53 | Manoela Heringer | Denv-4 in Rio de Janeiro: Epidemiology and Characterization of Confirmed Cases | Epidemiology |
| R-54 | Maria Mercedes Gonzalez | Dengue in Quindío Department 2007-2013 | Epidemiology |
| R-55 | Mariana Cunha | Zika Virus Detection After Blood Transfusion in Brasil , 2015 | Epidemiology |
| R-56 | Mayara Romero Canal | Identification of Priority Areas for Dengue Control through Spatiotemporal Clusters | Epidemiology- Modeling |
| R-57 | Mayling Alvarez Vera | Secondary Infection and Viral Infection Sequences Involved in the Severity of Dengue Cases | Epidemiology |
| R-58 | Nuncio Antonio Araujo Sol | Gis for Dengue Prevention in Brasil from the Municipal Database | Epidemiology |
| R-59 | Nuncio Antonio Araujo Sol | Municipal Database and Contingency Plan for Dengue Prevention in Brasil | Epidemiology |
| R-60 | Pedro Fragoso | Bacillus thuringiensis an alternative for the biological control of Aedes aegypti | Vector Control |
| R-61 | Rebecca C Christofferson | Zika: When to Apply Lessons Learned from Dengue and Chikungunya | Epidemiology |
| R-62 | Ricardo Marquez | Assessment of Aedes spp vectors of Dengue in Panama | Vector Biology |
| R-63 | Ronald Morales-Vargas | Chikungunya Transmission Virological Features in a Dengue Hyperendemic Grounds: Guatemala | Epidemiology |
| R-64 | Rose M. Langsjoen | Chikungunya fever outbreak in La Romana, Dominican Republic, Summer 2014 | Epidemiology |
| R-65 | Rosmari Rodriguez-Roche | Insights Into the Molecular Epidemiology of Dengue Viruses in Cuba | Epidemiology-Phylogenetics |
| R-66 | Sara. M. Sosa-Delgado | Infection of the perivascular cells with dengue virus | Virology |
| R-67 | Skylar Chelton | GIS-Based Buffers and Mosquito Infestation: Effective Tool to Control Dengue | Epidemiology- Modeling |
| R-68 | Tatiana Sierra Rivera | Mapping the Epidemiology of Chikungunya in Touristic Locations of Colombia During 2014-215: Implications for Travelers | Epidemiology |
| R-69 | Tereza Magalhaes | Arboviral Infections in Patients with Acute Fever | Epidemiology |
| R-70 | Tereza Magalhaes | Establishing a Brasilian Cohort of Patients with Acute Febrile Illnesses | Epidemiology |
| R-71 | Thais Riback | Infodengue Rio: a Nowcasting System for the Surveillance of Dengue Fever in Rio de Janeiro, Brasil | Epidemiology- Modeling |
| R-72 | Veronica Bravo de la Cruz | Molecular Epidemiology of Dengue in a Pediatric Population from México | Epidemiology-Phylogenetics |
| R-73 | Víctor Hugo Peña-García | Vectorial capacity of Aedes aegypti for DENV-2 in three Colombian cities | Vector Biology |
| R-74 | Yamitzel Zaldivar | Dengue Outbreak, Las Garzas, Panama, 2015. | Epidemiology |
| R-75 | Yanisley Martínez López | Estudio de la edad fisiologica de poblaciones de aedes aegypti en la habana, 2004-2014 | Vector ecology |
Friday 22nd: Pathogenesis, Antivirals, Clinical manifestations, Immunology, Vaccines, Diagnostics
Please see the list to find your poster number. Posters have been organised mainly so people presenting mor ethan one can have all their posters at proximity.
Unmounting posters: Finished the poster display (aprox. 7:30 pm) you are responsible to unmount your poster. Any remained posters will be taken away and disposed the next day at 8 am (exception for posters that are part of two sessions).
Looking forward seeing you in Panama City in April.
| Friday April 22nd | see the pdf file | |||
| Poster session: Pathogenesis, Antivirals, Clinical manifestations, Immunology, Vaccines, Diagnostics | ||||
| Highlighted posters | ||||
| Poster # | Name of presenter | Title | Session | |
| H-19 | James Brien | Mouse model of antibody-enhanced Dengue virus infection | Pathogenesis | |
| H-20 | Andrea Trujillo Correa | USE OF BIOINFORMATICS TO IDENTIFY INHIBITORS OF DENGUE VIRUS NS5-METHYLTRANSFERASE | Antivirals | |
| H-21 | Benedito Antonio Fonseca Lopes | Dengue neurological disease is most likely due to virus infection | Clinical | Poster Withdrawal |
| H-22 | Carolina de La Guardia | Antiviral activity of plant extracts and essential oils from Panamanian flora against dengue virus | Antivirals | |
| H-23 | Daniel N. Streblow | Characterization of Immunotherapeutic Efficacy During Chikungunya Virus Infection of Rhesus Macaques | Pathogenesis | |
| H-24 | Daniela Weiskopf | DENV-specific CD4 T-cells dominantly recognize capsid and display cytotoxic phenotypes | Immunology | |
| H-25 | Davis Beltran | Expression of ligands of NKG2D and DNAM-1 receptors by dengue infected cells and activation of NK cells cocultured with these cells | Immunology | |
| H-26 | Dhanasekaran Govindarajan | A Novel Combined Vaccine Approach against Dengue – A Pre-clinical Evaluation | Vaccines | |
| H-27 | Dimelza Arauz | Comparison between the sensitivity of indirect methods to detect antibodies against Chikungunya virus | Diagnostics | |
| H-28 | Douglas Widman | Strategy to measure DENV epitope-specific neutralizing antibody responses | Immunology | |
| H-29 | Eduardo Ramirez Vallejo | Electrocardiographic alterations in patients with chikungunya fever from Sucre, Colombia: A 42-case series | Clinical | |
| H-30 | Fernanda M de C Araújo | First documented cases of ZIKA virus Infection in Ceara, Brazil | Clinical | |
| H-31 | Giselle Barbosa Lima | DENGUE-ACTIVATED PLATELETS MODULATE MONOCYTE ACTIVATION THROUGH LIPID DROPLETS BIOGENESIS | Pathogenesis | |
| H-32 | Guillermo J Lagos Grisales | Post-chikungunya chronic inflammatory rheumatism: results from a retrospective follow-up study of 283 adult and children cases in La Virginia, Risaralda, Colombia | Clinical | |
| H-33 | Henry Puerta-Guardo | Flavivirus NS1 proteins differentially modulate endothelial permeability via the endothelial glycocalyx and intercellular junctions | Pathogenesis | |
| H-34 | Jael Miranda | Dengue patient sera factors effect over primary endothelium cell cultures | Pathogenesis | |
| H-35 | Jesica Swanstrom | Mapping antibody responses to a tetravalent dengue vaccine candidate (TDV) | Vaccines | |
| H-36 | Jessica Plante | Mapping the Impact of DENV-1 Genotypic Variation on Antibody Neutralization | Immunology | |
| H-37 | Karina R. Morales Gonzalez | Improving specificity of DENV E proteins through synthetic sequence redesign. | Diagnostics | |
| H-38 | Laura White | Next generation dengue vaccines with reduced potential for enhancement? | Vaccines | |
| H-39 | Priscila Castanha | Kinetics of dengue infection enhancing activity in Brazilian infants | Immunology | |
| H-40 | Patricia Sequeira | Systemic dissemination of Zika virus infection during an outbreak in Rio de Janeiro, Brazil | Diagnostics | |
| Regular posters | ||||
| R-76 | Adrienne Guignard | Modelling to inform dengue clinical trial design and interpretation | Vaccine | |
| R-77 | Shehana Tahir | Prevalence of post-Chikungunya Chronic Inflammatory Rheumatism: A Systematic Review and Meta-Analysis | Clinical | |
| R-78 | Alienys Izquierdo | ROLE OF THE CROSS-REACTIVE ANTIBODIES INDUCED BY DIII-C PROTEINS ON DENGUE INFECTION ENHANCEMENT. | Pathogenesis | |
| R-79 | Ana B. Perez | DENGUE VIRUS NS1 PROTEIN REGIONS AS TARGET OF IMMUNE RESPONSE | Pathogenesis | |
| R-80 | Andrea Trujillo Correa | USE OF BIOINFORMATICS TO IDENTIFY INHIBITORS OF DENGUE VIRUS NS5-METHYLTRANSFERASE | Antivirals | |
| R-81 | Angel Ambrocio AH | The β4 subunit of Cav1.2 Channels in Cardiac Cells Upregulates Interferon-related-Genes and Inhibits Dengue Virus Infection | Immunology | |
| R-82 | Barreto Debora | Immunocompetent Murine Model for the Pathogenesis Study of Dengue Viruses | Pathogenesis | |
| R-83 | Benedito Antonio Lopes da Fonseca | Dengue neurological disease is most likely due to virus infection | Clinical | Poster Withdrawal |
| R-84 | Berta Nelly Restrepo | Frequency of dengue infection in patients with neurological disease | Clinical | |
| R-85 | Betzana Zambrano | Adaptability of WHO Dengue Guidelines for a vaccine efficacy trial | Vaccine | |
| R-86 | Betzana Zambrano | Long-Term Safety of a CYD-TDV Dengue Vaccine in Asia DengueEndemic Countries | Vaccine | |
| R-87 | Carolina De La Guardia | Identification of peptides with binding activity to DENV-2 E glycoprotein | Antivirals | |
| R-88 | Cassia Fernanda Estofolete | Fever relevance in patients with dengue | Clinical | |
| R-89 | Cassia Fernanda Estofolete | DENGUE IN KIDNEY TRANSPLANT RECIPIENTS: REPORT OF 11 CASES FROM A CENTER | Clinical | |
| R-90 | Rosa Cetina-Trejo | Early detection of dengue virus by capture IgE ELISA test | Diagnostic | |
| R-91 | Cesar Lam | Dengue and Leptospira coinfection- A case study. | Clinical | |
| R-92 | Courtney Veilleux | Dengue Infection Compromises the Survival and Function of Human Monocytes: Implications in Transmigration | Pathogenesis | |
| R-93 | Daniel Arellanos-Soto | Evaluation of interferon response profiles induced by different Dengue viral strains isolated from Mexican patients | Immunology | |
| R-94 | Daniele Cristina Passos da Rocha | Dengue virus NS1 protein increases dehydrogenase glyceraldehyde – 3 – phosphate (GAPDH) activity | Pathogenesis | |
| R-95 | Danielle Malta Lima | Dengue clinical profile in the last four years in Fortaleza | Clinical-Diagnostic | |
| R-96 | ADRIANA ROLIM | Antiviral activity of the Acrocomia aculeata against the dengue virus | Antivirals | |
| R-97 | Danilo Casimiro | Phase I Safety/Immunogenicity of a Tetravalent Subunit Dengue Vaccine | Vaccine | |
| R-98 | David Alejandro Calle | COMPARISON OF DIAGNOSTIC TESTS FOR DENGUE, CHIKUNGUNYA AND WEST NILE | Diagnostic | |
| R-99 | Diana Patricia Londono | DENGUE-CHICUNGUNYA COINFECTION IN QUINDIO, COLOMBIA, IN 2015 | Clinical | |
| R-100 | Eduardo Nascimento | IgG RESPONSE TARGETING A DV3-NS1 EPITOPE ASSOCIATES WITH PROTECTION AGAINST DENGUE SEVERITY | Immunology | |
| R-101 | Elizabeth A. Dietrich | Transmission potential of Takeda’s dengue vaccine candidates in Aedes albopictus | Vaccine | |
| R-102 | Emily Gallichotte | Diversity across DENV2 type-specific antibody epitopes | Immunology | |
| R-103 | Federico Perdomo Celis | DYSFUNCTION OF PERIPHERAL BLOOD MONONUCLEAR CELLS IN NATURALLY INFECTED CHILDREN | Pathogenesis | |
| R-104 | Fernanda M. C. de Araujo | Neurological manifestations of DENV in fatal cases Ceará, Brasil | Clinical | |
| R-105 | Fernanda Cunha Jácome | Morphological and Viremia Analysis of Mice Infected with Dengue 2 | Pathogenesis | |
| R-106 | Gissel Garcia | PERSISTENCE OF SYMPTOMS POST DENGUE INFECTION: ASSOCIATION WITH IMMUNOLOGICAL MARKERS | Pathogenesis | |
| R-107 | Harrison Herrera Delgado | DETECTION OF PLASMA TUMOR NECROSIS FACTOR-a: A COMPARISON IN PEDIATRIC DENGUE | Diagnostic | |
| R-108 | Heather Friberg | Cellular immune responses TO a tetravalent dengue purified inactivated vaccine | Vaccine | |
| R-109 | Izabella Andrade Batista | DESIGNING CHIMERICAL DENGUE PROTEINS APPLIED TO MULTISEROTYPE VACCINES | Vaccine | |
| R-110 | James D. Brien | Immune system based therapeutics protect against antibody enhanced Dengue immunopathogenesis | Antivirals | |
| R-111 | Jared Pitts | Monitoring dengue RNA synthesis/decay in the presence of viral inhibitors | Antivirals | |
| R-112 | Jessie Pari | EVALUATION OF A COMERCIAL ELISA METHOD FOR CHIKUNGUNYA VIRUS EN PERÚ | Diagnostic | |
| R-113 | Jesús Vizoso-Quintana, | Is Caspase-1 required for early secretion of Il-1b Dengue infection? | Immunology | |
| R-114 | Joanna L. Miller | Effects of iminosugars on expression and function of macrophage receptors important in dengue virus disease | Antivirals | |
| R-115 | Jorge Andrés Castillo | Monocyte early and late response upon DENV infection | Immunology | |
| R-116 | Julio García-Cordero | NS3 protein of Dengue is located in MRD of HMEC-I. | Pathogenesis | |
| R-117 | Kame Alberto Galan Huerta | Clinical manifestations of Chikunungya virus infection in Mexican population | Clinical | |
| R-118 | Karla Fabiane Lopes de Melo | Evaluation of the miRNA pathway activity during DENV-4 infection | Immunology | |
| R-119 | Katerine Marin | Platelet activation in dengue patients, Colombia | Severity Markers | |
| R-120 | Kenneth Plante | The Collaborative Cross Identifies Genetic Determinants of Chikungunya Pathology | Pathogenesis | |
| R-121 | Leidy Lorena García | Curcumin assessment on ARN polymerase of Dengue Virus 2 | Antivirals | |
| R-122 | Leticia Castillo | Dengue-Duo Validation for diagnosis/surveildengue in Guatemala | Diagnostic | |
| R-123 | Leyi Lin | Tetravalent dengue heterologous prime-boost vaccination: One month Safety and Immunogenicity | Vaccine | |
| R-124 | Lisseth Saenz | Development of Diagnostic Methods for Detecting Specific Genotypes of Chikungunya. | Diagnostic | |
| R-125 | Lucile Warter | Preclinical characterization of a tetravalent dengue purified inactivated vaccine candidate | Vaccine | |
| R-126 | Luisa Alvarado | Early indicators of dengue among children and adults, Puerto Rico | Severity Markers | |
| R-127 | Ma Isabel Salazar | Effect in vitro of thalidomide on DENV infected cells | Immunology | |
| R-128 | Margarita Ochoa Diaz | Dengue, Zika or Chikungunya, another arbovirus between us | Clinical | |
| R-129 | Michael Rossman | Cryo-electron microscopy characterization of Chikungunya virus interacting with monoclonal antibodies | Immunology | |
| R-130 | Min Li | Elicitation of dengue virus neutralizing antibodies with divergent subunit vaccines | Vaccine | |
| R-131 | Moisés León-Juarez | Recombinant DENV NS2B protein alters membrane permeability in different models membranes | Pathogenesis | |
| R-132 | Monique R Queiroz Lima | Alternative Production of Recombinant Envelope Tetra-Epitope Antigen Produced In Transplastomic Lettuce | Diagnostic | |
| R-133 | Monique Trugilho | Quantitative proteomic analysis of HepG2 cell expressing the Dengue Virus NS1 protein | Pathogenesis | |
| R-134 | Natal Santos de Silva | Risk factors associated with hospitalization for dengue | Clinical | |
| R-135 | Nathália Furlan Barbosa | Test value of the tourniquet for patients suspected dengue | Diagnostic | |
| R-136 | Owen Bryan-Marrugo | Modulation of Cholesterol Pathway has Significant Effect on the Antiviral Capacity of Liver Cells against Dengue Virus | Antivirals | |
| R-137 | Ana Fernandez-Sesma | Phenotypical differences of DENV-2 and DENV-4 in human primary systems | Immunology | |
| R-138 | Robert Hontz | Antibody Avidity and Subclass in Symptomatic and Inapparent Dengue Infections | Immunology | |
| R-139 | Rosa Ramírez | Recombinant ns3 protein from dengue-2 induce functional cell-mediated immunity in mice | Vaccine | |
| R-140 | Silvia Fonseca | Dengue patients in a private hospital in Ribeirao Preto, Brasil | Clinical | |
| R-141 | Stefan W. Metz | Particulate display of DENV-E proteins induces robust neutralizing antibody responses. | Vaccine | |
| R-142 | Tereza Magalhaes | Dengue virus growth in mosquito and mammalian cells with distinct immune phenotypes | Immunology | |
| R-143 | Usha Nivarthi | Mapping human neutralizing antibody responses to dengue virus serotype 4 | Immunology | |
| R-144 | Victor R. DeFilippis | Anti-Arboviral Efficacy of Innate Immune Activation by Novel Small Molecules | Antivirals | |
| R-145 | Virginia Nunez Samudio | A case from panama of dengue coexistent with hantavirus pulmonary syndrome | Clinical | |
| R-146 | Wendy Murillo | Evaluation of a Commercial Serologic Diagnostic Test for Chikungunya Virus | Diagnostic | |
| R-147 | Yerly Useche | STING/IRF3 polymorphisms are associated with Dengue severity in Colombian children | Pathogenesis | |
| R-148 | Mariana Ruiz Silva | Mechanisms of MCP-1 upregulation upon CHIKV infection in human peripheral blood mononuclear cells | Immunology | |
| 94 posters | ||||
